Candel Therapeutics files investor presentation; no new material facts disclosed

Candel Therapeutics, Inc.

Candel Therapeutics furnished a corporate investor presentation dated September 2026 under Regulation FD.
Visible exhibit content is limited to the cover slide; no financial or clinical data is included in the filing text.
Presentation tagline: 'Tipping the balance in favor of the immune system to fight cancer.'
No earnings, guidance, or pipeline updates are disclosed in this 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.